We recently published a list of 10 Biggest Stocks with Negative Beta to Consider. In this article, we are going to take a ...
Medpage Today on MSN4d
Gene Therapy Details Revealed in Duchenne TrialSAVANNAH, Ga. -- Delandistrogene moxeparvovec (Elevidys), a gene therapy approved to treat Duchenne muscular dystrophy, ...
A Pfizer result is unsettling the gene therapy push for Duchenne muscular dystrophy: The boys didn't improve even though a ...
Jefferies initiates buy coverage on Sarepta Therapeutics (SRPT) due to Duchenne muscular dystrophy franchise and strong ...
A Phase 3 clinical trial investigating Elevidys (delandistrogene moxeparvovec), a gene therapy for Duchenne muscular ...
Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. | Pfizer has told 75 ...
On Friday, Capricor Therapeutics (NASDAQ:CAPR) announced 3-year safety and efficacy results from its ongoing HOPE-2 ...
EMA re-confirms non-renewal of conditional marketing authorisation of Duchenne muscular dystrophy medicine, Translarna: Amsterdam, The Netherlands Monday, October 21, 2024, 10:00 ...
We hypothesize that Duchenne muscular dystrophy and autism spectrum disorder/pervasive developmental disorder co-occur with a greater than random frequency. In this study, we set out to reject the ...
The agency has reconfirmed its recommendation to not give positive opinion to Translarna (ataluren) after a reexamination of the available data.
In 2020, Zander Teubes, aka ‘Zan the Man’, was diagnosed with Duchenne muscular dystrophy, which causes skeletal and heart muscle weakness and progressively worsens. He needs a wheelchair to move ...
Pfizer suffered a blow earlier this month when new data showed that its gene therapy for Duchenne muscular dystrophy failed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback